Original Source(s)
Related Content
Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial
An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.
by Teraya Smith
July 23, 2026
-
3 min
FDA Monthly Preview: Key August Decisions to Watch
Several FDA decisions across multiple specialties are expected this month.
July 30, 2026
-
5 min